Skip to content
Screener

OrthoPediatrics KIDS Q2 2025 earnings

Reported August 5, 2025 · After market close

Revenue$61.1MMiss by $317.6K
EPS-$0.11Beat by $0.06
Revenue estimate$61.4M
EPS estimate-$0.17

Next report

Oct 27, 2026 (in a month)
Revenue estimate$68.5M
EPS estimate-$0.25

Financials

Q2 2025

Income statement

See full
Revenue$61.1M+15.7%
Gross profit$44.0M+7.9%
Operating income-$10.7M-88.1%
Net income-$7.1M-18.0%
EPS (diluted)-$0.30-15.4%

Balance sheet

See full
Cash & equivalents$46.6M+50.9%
Total debt$1.4M-90.3%
Total equity$355.5M-4.2%
Total assets$503.6M+16.9%

Cash flow

See full
Operating cash flow-$10.5M-71.7%
CapEx$3.4M-48.5%
Free cash flow-$13.9M-8.9%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$530.8M-19.1%
Enterprise value$485.56M-24.1%
P/S2.4×-1.3×

Profitability

See full
Gross margin71.5%-3.1pp
Operating margin-18.7%+3.8pp
Net margin-18.9%+8.9pp
FCF margin-17.1%-4.7pp

Returns & leverage

See full
Return on equity-11.5%+29.5pp
Debt / equity0×0.0×
Current ratio6.7×+1.8×

Segments

By product

See full
Trauma and deformity$41.7M+10.3%
Scoliosis$18.5M+35.4%
Sports medicine/other$905.0K-32.9%

By geography

See full
U.S.$48.1M—

FAQ

When did OrthoPediatrics report Q2 2025 earnings?
OrthoPediatrics (KIDS) reported Q2 2025 earnings on August 5, 2025 after market close.
What were OrthoPediatrics's Q2 2025 revenue and EPS?
OrthoPediatrics reported revenue of $61.1M and eps of $-0.11 for Q2 2025.
Did OrthoPediatrics beat estimates in Q2 2025?
Revenue missed the consensus estimate of $61.4M by $317.6K. EPS beat the consensus estimate of $-0.17 by $0.06.
How did OrthoPediatrics's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 15.7% from $52.8M a year earlier and eps grew 52.2% from $-0.23.
Where can I find OrthoPediatrics's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001425450-25-000093) and the 10-Q periodic report (0001425450-25-000096) directly on SEC EDGAR. The filing index links above go to sec.gov.